[CTRL-Labs](/companies/ctrl-labs) developed non-invasive [brain-computer interface](/technologies/brain-computer-interface) technology with applications in [neurorehabilitation](/therapeutics/neurorehabilitation) for [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [stroke](/diseases/stroke).
CTRL-Labs was a pioneering neurotechnology company founded in 2015 that developed non-invasive neural interface technology based on electromyography (EMG). The company's wrist-worn devices captured neural signals at the muscle level, decoding movement intentions before they resulted in physical motion—representing a fundamentally different approach compared to invasive brain-computer interfaces like Neuralink or BrainGate. CTRL-Labs was acquired by Meta (then Facebook) in September 2019 for reported $500 million to $1 billion, representing one of the largest acquisitions in the brain-computer interface (BCI) space. Following acquisition, the company's technology was integrated into Meta's Reality Labs division to develop next-generation augmented and virtual reality (AR/VR) input methods, most notably through Project Nazare. The acquisition marked a significant validation of non-invasive neural interface technology and accelerated industry investment in consumer neurotechnology applications.
[CTRL-Labs](/companies/ctrl-labs) developed non-invasive [brain-computer interface](/technologies/brain-computer-interface) technology with applications in [neurorehabilitation](/therapeutics/neurorehabilitation) for [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [stroke](/diseases/stroke).
CTRL-Labs was a pioneering neurotechnology company founded in 2015 that developed non-invasive neural interface technology based on electromyography (EMG). The company's wrist-worn devices captured neural signals at the muscle level, decoding movement intentions before they resulted in physical motion—representing a fundamentally different approach compared to invasive brain-computer interfaces like Neuralink or BrainGate. CTRL-Labs was acquired by Meta (then Facebook) in September 2019 for reported $500 million to $1 billion, representing one of the largest acquisitions in the brain-computer interface (BCI) space. Following acquisition, the company's technology was integrated into Meta's Reality Labs division to develop next-generation augmented and virtual reality (AR/VR) input methods, most notably through Project Nazare. The acquisition marked a significant validation of non-invasive neural interface technology and accelerated industry investment in consumer neurotechnology applications.
| Attribute | Details |
|-----------|---------|
| Company Name | CTRL-Labs Corporation |
| Headquarters | New York, New York, USA |
| Founded | 2015 |
| Acquired By | Meta Platforms (formerly Facebook) |
| Acquisition Date | September 2019 |
| Acquisition Value | Reported $500M-$1B |
| Status | Defunct (integrated into Meta Reality Labs) |
| Primary Technology | Wrist-worn EMG neural interface |
| Co-Founders | Thomas Reardon, Patrick Kaifosh |
CTRL-Labs represented a unique position in the neural interface landscape by focusing exclusively on non-invasive surface electromyography rather than invasive cortical implants. This approach offered significant advantages in terms of safety, accessibility, and consumer adoption potential while still providing sufficient signal quality for complex movement decoding[@emg_fundamentals][@motor_decoding].
CTRL-Labs was founded in 2015 by Thomas Reardon and Patrick Kaifosh, bringing together expertise in neuroscience, software engineering, and consumer hardware development. The company's formation coincided with a broader resurgence of interest in brain-computer interface technologies, driven by advances in machine learning, signal processing, and miniaturization of electronics.
Thomas Reardon, the company's CEO and co-founder, brought significant technical credentials to the venture. Prior to founding CTRL-Labs, Reardon was a senior executive at Microsoft, where he led development of the Internet Explorer browser and later worked on technology strategy. This background in consumer software and user interface design shaped CTRL-Labs' approach to developing intuitive neural interfaces that could be seamlessly integrated into everyday computing experiences.
Patrick Kaifosh, co-founder and neuroscience lead, contributed expertise in computational neuroscience and neural signal processing. His research background focused on understanding motor control mechanisms and developing algorithms for decoding neural activity—a critical foundation for the company's EMG-based approach to movement prediction.
Between 2015 and 2019, CTRL-Labs developed its core technology platform and established itself as a leading non-invasive neural interface company. The company raised Series A and Series B funding to support technology development and built partnerships with academic research institutions and technology companies.
During this period, CTRL-Labs:
In September 2019, CTRL-Labs was acquired by Meta Platforms (then known as Facebook) in what represented one of the largest acquisitions in the neural interface space. The reported acquisition price of $500 million to $1 billion reflected both the strategic importance of neural interface technology for Meta's AR/VR ambitions and the technical achievements of CTRL-Labs' team.
The acquisition aligned with Meta's broader investment in Reality Labs, the division responsible for developing augmented and virtual reality products including the Quest VR headset. Neural interfaces represented a potential "next input method" for immersive computing environments where traditional keyboards, mice, and touchscreens were impractical.
Following the acquisition, CTRL-Labs' technology and personnel were integrated into Meta's research efforts. The company ceased independent operations, and its technology development continued under Meta's Reality Labs division.
[CTRL-Labs](/companies/ctrl-labs) core technology leveraged electromyography (EMG)—the technique of recording electrical activity produced by skeletal muscles. Unlike invasive [brain-computer interfaces](/technologies/brain-computer-interface) that require surgical implantation of electrodes into [brain tissue](/brain-regions/cortex), CTRL-Labs' approach used surface electrodes placed on the skin above target muscle groups[@emg_fundamentals].
The fundamental innovation of [CTRL-Labs](/companies/ctrl-labs) was positioning the sensors at the wrist, capturing signals from the motor nerves that control hand and finger movements. This location provided several advantages:
| Component | Description |
|-----------|-------------|
| Sensor Array | Multiple surface EMG electrodes integrated into a wrist-worn device |
| Signal Bands | Captures electrical activity in the frequency range typical for motor unit action potentials (10-500 Hz) |
| Sampling Rate | High-frequency sampling to capture fine-grained muscle activation patterns |
| Form Factor | Lightweight wristband compatible with everyday wear |
| Connectivity | Wireless connection to companion devices via Bluetooth |
CTRL-Labs developed a sophisticated signal processing pipeline to translate raw EMG data into actionable movement predictions:
CTRL-Labs' algorithms leveraged modern machine learning techniques, particularly deep neural networks, to achieve high accuracy gesture recognition:
CTRL-Labs' non-invasive approach represented a fundamentally different strategy compared to companies developing invasive brain-computer interfaces:
| Characteristic | CTRL-Labs (Non-Invasive EMG) | Invasive Cortical BCIs |
|---------------|------------------------------|------------------------|
| Invasiveness | Surface sensors, no surgery | Surgical implantation required |
| Signal Source | Peripheral motor nerves | Motor cortex neurons |
| Information Bandwidth | Moderate (hand/finger movements) | High (detailed movement parameters) |
| Safety | Minimal risk | Surgical risks, infection potential |
| Long-term Stability | Requires calibration maintenance | Electrode degradation over time |
| Consumer Readiness | High (wearable form factor) | Low (medical procedure required) |
| Latency | Low (closer to motor output) | Variable (depends on recording location) |
Both approaches offered unique advantages, and the field continued to explore which applications were best suited to each approach. For consumer applications requiring safety, comfort, and accessibility, non-invasive EMG offered clear advantages[@invasive_vs_noninvasive][@bci_control_signals].
Prior to the Meta acquisition, CTRL-Labs released the CTRL-Kit developer platform, enabling researchers and developers to explore applications of the company's technology:
Hardware Components:
Following the 2019 acquisition, CTRL-Labs' technology was incorporated into Meta's Reality Labs research division:
Project Nazare was Meta's prototype for neural interface-enabled AR glasses. Unlike traditional VR headsets that required controllers or hand tracking cameras, Nazare aimed to use neural interfaces to enable "hands-free" interaction with digital content:
Meta's Reality Labs continued developing neural interface technology for AR/VR applications:
Thomas Reardon served as CEO and brought extensive experience from Microsoft where he led development of Internet Explorer and other key products. His vision for CTRL-Labs was to create neural interfaces that felt natural and intuitive—technology that faded into the background while enabling new forms of human-computer interaction.
Patrick Kaifosh served as co-founder and led the neuroscience research efforts. With a background in computational neuroscience, he focused on developing the algorithms and signal processing approaches that made CTRL-Labs' gesture recognition possible.
CTRL-Labs benefited from guidance from prominent neuroscience researchers:
Konrad Kording served as a scientific advisor, bringing expertise in computational neuroscience and neural data science. His research on neural decoding and motor control provided important foundations for the company's technical approach.
The company established partnerships with academic research institutions exploring motor control, rehabilitation, and human-computer interaction:
EMG-based interfaces represented an active area of research in neural engineering, with applications ranging from prosthetic control to human-computer interaction[@emg_fundamentals][@motor_decoding]:
Motor Unit Physiology: EMG signals arise from the aggregate electrical activity of motor units—collections of muscle fibers innervated by a single motor neuron. When the brain initiates a movement, motor neurons fire action potentials that propagate to muscle fibers, causing contraction. The sum of all motor unit activities in a muscle produces the detectable EMG signal.
Movement Decoding: The patterns in EMG signals encode information about the intended movement, including:
Developing robust EMG-based interfaces required addressing several technical challenges:
CTRL-Labs addressed these challenges through machine learning approaches that could adapt to individual users and maintain performance across varying conditions[@emg_classification][@neural_signal_processing].
EMG-based neural interfaces had applications beyond consumer electronics:
Prosthetic Control: Myoelectric prosthetic hands used EMG signals from residual muscles to control motorized hand prostheses. CTRL-Labs' technology represented an advance over traditional myoelectric approaches by providing more detailed movement information.
Neurorehabilitation: EMG biofeedback had been used in rehabilitation settings to help patients recover motor function after stroke or spinal cord injury. Neural interfaces could provide more sophisticated feedback and training paradigms.
Neuroscience Research: EMG recordings were fundamental tools for studying motor control and the neural basis of movement[@motor_cortex][@emg_rehabilitation].
CTRL-Labs operated in a rapidly evolving competitive environment:
| Company | Approach | Status |
|---------|----------|--------|
| Neuralink | Invasive cortical implants | Active development |
| BrainGate | Invasive intracortical arrays | Clinical trials |
| Synchron | Stentrode (vascular BCI) | Clinical trials |
| Kernel | Non-invasive neural imaging | Research stage |
| Cerebras | Brain computing (co-processors) | Research stage |
The competitive landscape demonstrated multiple approaches to neural interface technology, each with different tradeoffs between invasiveness, signal quality, and consumer accessibility. CTRL-Labs' focus on non-invasive EMG positioned the company uniquely for consumer applications[@bci_startup][@invasive_vs_noninvasive].
The neural interface market represented significant opportunity:
Neural interface technology raised important ethical questions that CTRL-Labs and the broader field needed to address[@bci_ethics]:
The company needed to consider these issues as the technology moved toward broader deployment.
The Meta acquisition represented significant validation of non-invasive neural interface technology:
CTRL-Labs contributed to advancing the state of the art in several areas:
Following the acquisition, Meta continued developing neural interface technology:
CTRL-Labs' approach influenced subsequent developments in the neural interface space:
As of the current date, CTRL-Labs as an independent company no longer exists. The technology and expertise developed by the company continue to influence Meta's research efforts in neural interfaces and AR/VR input methods.
Meta's Reality Labs continues to develop neural interface technology:
The neural interface field continued to evolve:
The fundamental technology pioneered by CTRL-Labs—using EMG signals from the wrist to decode movement intentions—remained a viable approach for neural interface development. The approach offered a balance of signal quality, safety, and consumer accessibility that made it suitable for a range of applications.
CTRL-Labs represented a significant chapter in the development of neural interface technology. By pioneering non-invasive EMG-based neural interfaces, the company demonstrated that meaningful brain-computer communication could be achieved without surgical implantation—opening possibilities for consumer applications that had previously seemed impossible.
The company's acquisition by Meta validated both the technology and the strategic importance of neural interfaces for next-generation computing platforms. While CTRL-Labs as an independent entity no longer exists, the technology and expertise developed by the company continue to influence the field through Meta's ongoing research and the broader impact on the neurotechnology industry.
CTRL-Labs' legacy includes demonstrating that:
Related Hypotheses: